Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Levamisole and human lymphocyte surface markers.

J Wybran, A Govaerts

    Clinical and Experimental Immunology
    |February 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Recurrent depressive disorder associated with an atypical CADASIL syndrome].

    Tijdschrift voor psychiatrie·2024
    Same author

    The influence of heredity in the etiology of tuberculosis.

    The Eugenics review·2011
    Same author

    [Jules Bordet (1870-1961)].

    Revue medicale de Bruxelles·1999
    Same author

    Posthypoxic midbrain tremor.

    Movement disorders : official journal of the Movement Disorder Society·1998
    Same author

    [Eulogy of Professor Jules Bordet, Nobel Prize in Medicine and Physiology in 1919].

    Bulletin et memoires de l'Academie royale de medecine de Belgique·1994
    Same author

    [Integration of carcinogenic viruses in the genome of in-vitro cultured human fibroblasts].

    Bulletin et memoires de l'Academie royale de medecine de Belgique·1991

    Levamisole treatment in vitro significantly boosted T-cell numbers by enhancing T-cell receptor expression. However, it reduced B-cell numbers by decreasing C3 receptor expression on lymphocytes.

    Area of Science:

    • Immunology
    • Pharmacology

    Background:

    • Levamisole is an immunomodulatory drug with complex effects on immune cells.
    • Understanding its specific actions on human lymphocytes is crucial for therapeutic applications.

    Purpose of the Study:

    • To investigate the in vitro effects of various levamisole concentrations on normal human lymphocytes.
    • To quantify the impact of levamisole on T-cell and B-cell populations.

    Main Methods:

    • Utilized rosette assays, including active and total T-rosette tests with SRBC, to quantify T cells.
    • Employed the EAC assay to quantify B cells.
    • Assessed levamisole concentrations ranging from 10(-1) mg to 10(-8) mg%.

    Main Results:

    • A concentration of 10(-3) mg% levamisole significantly increased the percentages of both active and total T cells.

    Related Experiment Videos

  • Conversely, levamisole concentrations between 10(-2) and 10(-7) mg% significantly decreased the percentage of B cells (EAC assay).

    • Conclusions:

    • Levamisole at specific concentrations promotes enhanced expressivity of the T-cell receptor.
    • Levamisole also decreases the expressivity of the C3 receptor on B cells, indicating differential effects on lymphocyte subsets.